Creea Shannon

Creea
Shannon
PhD Student
Department of Biomedical Informatics
creea.shannon@vanderbilt.edu

Creea Shannon completed her Master of Science degree in Data Science in May 2021 from Lipscomb University. She served as an intern for the White House Office of Science and Technology Policy team. Her work helped ensure that clean energy transition improves health outcomes for vulnerable populations. 

As a STEM and health advocate, she has research interests in HIV and the prevention and treatment of diseases that are prevalent in underserved communities.

LinkedIn: https://www.linkedin.com/in/creeashannon/

https://voice.vumc.org/grad-student-creea-shannon-seeks-to-inspire-youn…

David Foutch

David
Foutch
MS Student
Department of Biomedical Informatics
2525 West End Avenue
d.foutch@vumc.org

Completed his Master of Science degree in Genome Science and Technology in January 2020. David is a Statistical Analyst in the Department of Biomedical Informatics. He is pursuing a Master’s degree.

 

Nicole Neville

Nicole
Neville
Clinical Trials Research Coordinator II
Department of Biomedical Informatics
2525 West End Avenue
Nashville
Tennessee
37203
nicole.neville@vumc.org

DBMI Catalyzing Informatics Innovation (CI2) Program: Applications Due August 1, 2022

We are excited to open this year's application window for the 2022-2023 DBMI Catalyzing Informatics Innovation (CI2) program. The CI2 program supports faculty in the development of early-stage, innovative and impactful informatics-based projects that have the potential to improve health, healthcare, or discovery. The CI2 Program awardees receive not only modest funding to pursue their proposed project, but also join a cohort of CI2 Fellows who work closely with faculty and VUMC leadership. 

DBMI Digest June 2022 Issue—Now Available!

The Vanderbilt University Medical Center (VUMC) Department of Biomedical Informatics's (DBMI) monthly newsletter, DBMI Digest, is now available to view. Read the June 2022 DBMI Digest here. Each DBMI Digest features department & faculty announcements, awards & appointments, educational & HR updates, funding opportunities and more. Each issue also includes a profile of one of our faculty, staff, postdocs and students. 

BioVU Celebrates 15 Years Supporting Personalized Medicine

In 2003, Dan Roden, MD, then director of the Division of Clinical Pharmacology at Vanderbilt University Medical Center, imagined a large-scale biobank integrated with electronic health records to help doctors “personalize” medical care for their patients.

About the CI Fellowship Program

Vanderbilt’s Fellowship Program in Clinical Informatics is a two-year program with both didactic and rotational training. This two-year fellowship is open to physicians who are ABMS board certified or board eligible in a primary specialty (e.g.

Jonathan Brett Heimlich, MD, PhD

Jonathan
Heimlich
Clinical Fellow
Vanderbilt Genomic Medicine Training Program, Cardiovascular Medicine
2525 West End Ave.
jonathan.b.heimlich@vumc.org

Dr. Heimlich is a VGM postdoctoral fellow in DBMI’s CPM and a cardiovascular medicine fellow. He is also a member of the Harrison Society, VUMC’s physician-scientist training program. He is originally from Alpharetta, Georgia and completed his MD and PhD Training at the Medical College of Georgia prior to studying Medicine and Cardiology at VUMC. 

Brett joined Alex Bick’s lab in July 2022 and his work has focused on somatic mosaicism as it relates to cardiovascular diseases. He has been utilizing single cell sequencing techniques in combination with additional methods to gain novel insight into clonal populations of peripheral blood cells that may uniquely contribute to the development of cardiovascular disease. 

Chris Guardo

Chris
Guardo
Master's Student
Department of Biomedical Informatics
2525 West End Avenue
Nashville
Tennessee
37203
chris.guardo@vumc.org

Chris Guardo (he/him) received his Bachelor of Science in mathematics and statistics from Belmont University (May 2022). Chris is a part-time student pursuing a master's degree and is an Associate Statistical Analyst in Wei-Qi Wei's lab. 

Assessment of a Naloxone Coprescribing Alert for Patients at Risk of Opioid Overdose

The drug naloxone can rapidly reverse an opioid overdose. In 2016 the Centers for Disease Control and Prevention (CDC) recommended that clinicians prescribing opioids for chronic pain consider coprescribing naloxone in patients with higher opioid dosages, a history of substance use disorder or overdose, or a concurrent benzodiazepine prescription.